Nov 2026· Frontiers in Surgery· Vol 13· 0 citations· 29 references
TL;DR
Data do not show a detectable association between weight-loss magnitude and thyroid hormone changes after LSG, although they do not establish equivalence; the exploratory ferritin signal warrants confirmation in prospective studies with comprehensive iron indices.
Abstract
In patients with obesity, thyroid-stimulating hormone (TSH) and free triiodothyronine (fT3) concentrations and the ratio of fT3 to free thyroxine (fT4) are often higher than in normal-weight individuals. Although laparoscopic sleeve gastrectomy (LSG) alters thyroid function, the temporal trajectory of these changes and the factors associated with them remain incompletely characterized. We therefore examined, in 232 patients followed for 12 months after LSG, how thyroid hormone parameters changed over the first postoperative year and which clinical and iron-related factors were associated with these changes.
In this retrospective cohort, patients (including 25 with treated autoimmune hypothyroidism) were assessed before surgery and at 6 and 12 months, with thyroid hormone trajectories analyzed by repeated-measures testing and their correlates examined by multivariable regression.
TSH, fT3, and the calculated fT3/fT4 ratio decreased significantly over 12 months while fT4 rose modestly; changes were evident at 6 months, with no statistically significant additional change detected between 6 and 12 months (TSH,
p
= 0.482). No statistically significant association was detected between the changes in TSH, fT3, and fT4 and weight-loss magnitude within the observed range of total weight loss (11.0%–48.3%), including in the 207 patients not receiving levothyroxine; in the adjusted model for the TSH change, a 10-percentage-point difference in total weight loss corresponded to −0.03 μIU/mL (95% CI −0.15 to +0.09). No statistically significant association was detected with the changes in inflammatory markers. Each change was most strongly associated with its own baseline value, but these associations partly reflect mathematical coupling, measurement error, and regression to the mean and are not interpreted as physiological effects. A weak, nominal association between the changes in TSH and ferritin was specification-dependent and is regarded as exploratory. Among levothyroxine-treated patients, the dose was reduced in 16 of 25 (64%; 95% CI 44.5–79.8), a descriptive observation that cannot be attributed to surgery alone.
Within the observed range, these data do not show a detectable association between weight-loss magnitude and thyroid hormone changes after LSG, although they do not establish equivalence; the exploratory ferritin signal warrants confirmation in prospective studies with comprehensive iron indices.
Objective: Obesity is associated with functional alterations in the hypothalamic–pituitary–thyroid (HPT) axis. Although bariatricsurgery induces substantial weight loss and metabolic improvement, postoperative thyroid hormone changes and potential differencesbetween surgical procedures remain unclear.Patients and Metho...
H. Gunhan, E. Imre, D. Gogas Yavuz· Marmara Medical Journal· 0 citations
Previous studies have suggested that the serum free triiodothyronine (FT3)/free thyroxine (FT4) ratio reflects thyroid hormone metabolism and may be altered in goitrous thyroid diseases. However, its relationship with thyroid volume (TV) in nontoxic nodular goiter remains unclear. We retrospectively analyzed 3,841 pati...
I. Monno, Mitsuru Ito, Mitsushige Nishikawa et al.· Endocrine journal· 0 citations
BACKGROUND
Hyperuricemia is highly prevalent among individuals with obesity and is associated with insulin resistance, chronic kidney disease, and cardiovascular risk. Although laparoscopic sleeve gastrectomy (LSG) reduces serum uric acid (SUA), the underlying mechanisms remain unclear. Emerging evidence suggests that...
The association between the free triiodothyronine-to-free thyroxine (FT3/FT4) ratio and thyroid nodules (TNs) remains unclear. This cross-sectional study examined this association in euthyroid patients with type 2 diabetes mellitus (T2DM). Between 2021 and 2023, we enrolled 934 patients with T2DM at Tianjin Medical Uni...
B. Huang, Xin Li, Da-Di Xie et al.· Frontiers in Medicine· 0 citations
Introduction: Driven by impaired insulin secretion and insulin resistance, type 2 diabetes mellitus (T2DM) stands as a chronic metabolic disorder. While metabolic bariatric surgery (MBS) is highly effective, data on older populations remain limited. The objective of this study is to assess the long-term outcomes and cl...
Paweł Jaworski, Mateusz Wityk, P. Major et al.· Journal of Clinical Medicine· 0 citations